Treatment adherence in patients with diffuse neuropsychiatric disorders associated with systemic lupus erythematosus

Andrea Cevallos Guerrero; Heidi Ángela Fernández; Ruth Jimbo Sotomayor; Gabriela Carolina Guevara; Diego Mera Orces; Fernando Naranjo-Saltos

doi:10.1016/j.rcreu.2020.12.003

Treatment adherence in patients with diffuse neuropsychiatric disorders associated with systemic lupus erythematosus

Título traducido de la contribución: Adherencia al tratamiento en pacientes con trastornos neuropsiquiátricos difusos asociados a lupus eritematoso sistémico

Andrea Cevallos Guerrero, Heidi Ángela Fernández, Ruth Jimbo Sotomayor, Gabriela Carolina Guevara, Diego Mera Orces, Fernando Naranjo-Saltos

Facultad de Medicina

Producción científica: Contribución a una revista › Artículo › revisión exhaustiva

1 Cita (Scopus)

Resumen

Introduction: Systemic lupus erythematosus (SLE) is a chronic disease that affects multiple systems and may include neurological and psychiatric events that could compromise treatment adherence and long-term outcomes in SLE. Objective: To evaluate treatment adherence in patients with diffuse neuropsychiatric disorders associated with SLE. Methodology: A cross-sectional descriptive study was conducted. Treatment adherence was evaluated with the Morisky Medication Adherence Scale (MMAS-8) in patients with diffuse neuropsychiatric disorders associated with SLE (cognitive impairment, psychosis, mood disorders, and anxiety). Results: A total of 60 patients with neuropsychiatric disorders associated with SLE were included. Thirteen patients (21.6%) had high adherence, 9 (15%) had medium adherence, and 38 patients (63.3%) had low treatment adherence. Conclusion: This study has identified that almost two-thirds of the participants (63.3%) had low treatment adherence.

Título traducido de la contribución	Adherencia al tratamiento en pacientes con trastornos neuropsiquiátricos difusos asociados a lupus eritematoso sistémico
Idioma original	Inglés
Páginas (desde-hasta)	26-30
Número de páginas	5
Publicación	Revista Colombiana de Reumatologia
Volumen	29
N.º	1
DOI	https://doi.org/10.1016/j.rcreu.2020.12.003
Estado	Publicada - 1 ene. 2022

Nota bibliográfica

Publisher Copyright:
© 2021 Asociación Colombiana de Reumatología

Acceder al documento

10.1016/j.rcreu.2020.12.003

Otros archivos y enlaces

Enlace a la publicación en Scopus

Citar esto

@article{7eb73b930de443edbcb1e9a2f7951cd2,

title = "Treatment adherence in patients with diffuse neuropsychiatric disorders associated with systemic lupus erythematosus",

abstract = "Introduction: Systemic lupus erythematosus (SLE) is a chronic disease that affects multiple systems and may include neurological and psychiatric events that could compromise treatment adherence and long-term outcomes in SLE. Objective: To evaluate treatment adherence in patients with diffuse neuropsychiatric disorders associated with SLE. Methodology: A cross-sectional descriptive study was conducted. Treatment adherence was evaluated with the Morisky Medication Adherence Scale (MMAS-8) in patients with diffuse neuropsychiatric disorders associated with SLE (cognitive impairment, psychosis, mood disorders, and anxiety). Results: A total of 60 patients with neuropsychiatric disorders associated with SLE were included. Thirteen patients (21.6%) had high adherence, 9 (15%) had medium adherence, and 38 patients (63.3%) had low treatment adherence. Conclusion: This study has identified that almost two-thirds of the participants (63.3%) had low treatment adherence.",

keywords = "Adherence, Anxiety, Depression, Ecuador, Lupus, Neuropsychiatric",

author = "{Cevallos Guerrero}, Andrea and Fern{\'a}ndez, {Heidi {\'A}ngela} and {Jimbo Sotomayor}, Ruth and Guevara, {Gabriela Carolina} and {Mera Orces}, Diego and Fernando Naranjo-Saltos",

note = "Publisher Copyright: {\textcopyright} 2021 Asociaci{\'o}n Colombiana de Reumatolog{\'i}a",

year = "2022",

month = jan,

day = "1",

doi = "10.1016/j.rcreu.2020.12.003",

language = "English",

volume = "29",

pages = "26--30",

journal = "Revista Colombiana de Reumatologia",

issn = "0121-8123",

publisher = "Asociacion Colombiana de Reumatologia",

number = "1",

}

Treatment adherence in patients with diffuse neuropsychiatric disorders associated with systemic lupus erythematosus. / Cevallos Guerrero, Andrea; Fernández, Heidi Ángela; Jimbo Sotomayor, Ruth et al.
En: Revista Colombiana de Reumatologia, Vol. 29, N.º 1, 01.01.2022, p. 26-30.

Producción científica: Contribución a una revista › Artículo › revisión exhaustiva

TY - JOUR

T1 - Treatment adherence in patients with diffuse neuropsychiatric disorders associated with systemic lupus erythematosus

AU - Cevallos Guerrero, Andrea

AU - Fernández, Heidi Ángela

AU - Jimbo Sotomayor, Ruth

AU - Guevara, Gabriela Carolina

AU - Mera Orces, Diego

AU - Naranjo-Saltos, Fernando

PY - 2022/1/1

Y1 - 2022/1/1

N2 - Introduction: Systemic lupus erythematosus (SLE) is a chronic disease that affects multiple systems and may include neurological and psychiatric events that could compromise treatment adherence and long-term outcomes in SLE. Objective: To evaluate treatment adherence in patients with diffuse neuropsychiatric disorders associated with SLE. Methodology: A cross-sectional descriptive study was conducted. Treatment adherence was evaluated with the Morisky Medication Adherence Scale (MMAS-8) in patients with diffuse neuropsychiatric disorders associated with SLE (cognitive impairment, psychosis, mood disorders, and anxiety). Results: A total of 60 patients with neuropsychiatric disorders associated with SLE were included. Thirteen patients (21.6%) had high adherence, 9 (15%) had medium adherence, and 38 patients (63.3%) had low treatment adherence. Conclusion: This study has identified that almost two-thirds of the participants (63.3%) had low treatment adherence.

AB - Introduction: Systemic lupus erythematosus (SLE) is a chronic disease that affects multiple systems and may include neurological and psychiatric events that could compromise treatment adherence and long-term outcomes in SLE. Objective: To evaluate treatment adherence in patients with diffuse neuropsychiatric disorders associated with SLE. Methodology: A cross-sectional descriptive study was conducted. Treatment adherence was evaluated with the Morisky Medication Adherence Scale (MMAS-8) in patients with diffuse neuropsychiatric disorders associated with SLE (cognitive impairment, psychosis, mood disorders, and anxiety). Results: A total of 60 patients with neuropsychiatric disorders associated with SLE were included. Thirteen patients (21.6%) had high adherence, 9 (15%) had medium adherence, and 38 patients (63.3%) had low treatment adherence. Conclusion: This study has identified that almost two-thirds of the participants (63.3%) had low treatment adherence.

KW - Adherence

KW - Anxiety

KW - Depression

KW - Ecuador

KW - Lupus

KW - Neuropsychiatric

UR - http://www.scopus.com/inward/record.url?scp=85101624759&partnerID=8YFLogxK

U2 - 10.1016/j.rcreu.2020.12.003

DO - 10.1016/j.rcreu.2020.12.003

M3 - Article

AN - SCOPUS:85101624759

SN - 0121-8123

VL - 29

SP - 26

EP - 30

JO - Revista Colombiana de Reumatologia

JF - Revista Colombiana de Reumatologia

IS - 1

ER -

Treatment adherence in patients with diffuse neuropsychiatric disorders associated with systemic lupus erythematosus

Resumen

Nota bibliográfica

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto